chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented to community clinic requesting a Covid-19 vaccination.  He reported that he had not previously received a Covid-19 vaccination.  Incentives were being offered.
PATIENT STARTED FEELING HOT, NAUSEA, TINGLING IN FINGERS AND FEET, HANDS WERE RIGID. HE WAS VERY UPSET AND CRYING. HE HAD PAIN IN HIS HANDS. EMT THOUGHT HE WAS HAVING A PANIC ATTACK
The patient had a decently large rectangular red, swollen area on her arm. She said that it was itchy too.
Bones of the extremities hurt; Shoulder hurts; Vertigo; Headache; Tiredness; Vaccine is very painful/which is where the vaccine is applied; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a 67-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had beginning of shingles), burning skin (felt a lot of burning where the leg started under the buttock), pruritus (felt a lot of itching where the leg started under the buttock), blister (patient's wife saw that they were little balls filled with liquid, an area about half an inch in diameter) and pimples (since previously legs had been filled from the waist down with some red-tipped pimples and they burned like acid, as he work cutting weeds and thought it was the effect of a poison ivy weed).   On 21st February 2023, the patient received Shingles vaccine. In February 2023, less than a week after receiving Shingles vaccine, the patient experienced injection site pain, vertigo, headache and tiredness. On 21st February 2023, the patient experienced shoulder pain. On 22nd February 2023, the patient experienced bone pain. On an unknown date, the outcome of the injection site pain, shoulder pain and bone pain were not recovered/not resolved and the outcome of the vertigo, headache and tiredness were unknown.   It was unknown if the reporter considered the injection site pain, shoulder pain, vertigo, headache, tiredness and bone pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 24-Feb-2023 Reporter's comments: The case was received from the patient via interactive digital media. The patient received the Shingles vaccine last Tuesday four days ago and warn that, the vaccine was very painful, after thirty minutes the shoulder starts to hurt, which was where the vaccine was applied. Less than a week after vaccination, the vaccine gave vertigo, headache, tiredness and the next day the bones of the extremities hurt. Until the day of reporting, the pain continues. The patient keep working because expenses and bills did not pay themselves.  The patient stated blessings for all. Additional supportive information: The follow-up could not be possible as no contact details were available.
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Body Aches Generalized-Mild, Systemic: Chills-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Blistering at site of injection and down the arm-Medium, Systemic: Headache-Mild, Additional Details: Pt presented 5 days post immunization with blistering at and around injection site on right arm. Day 1 post injection stated she had fever, chills, body aches, headaches. Day 2 said she had tingling in injection arm, but didn't see anything. Day 4 post injection she noticed blistering and redness at injection site and down her arm. Day 5, blistering still present and came into pharmacy to report
fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient have concomitant medication (unspecified). Treatment information was not provided by the reporter
24 HOURS AFTER VACCINE MOTHER NOTICED REDNESS, SWELLING, WARMTH AND TENDERNESS ABOUT 5 INCHES IN DIAMETER AROUND SIGHT OF INJECTION. THIS HAS GRADUALLY IMPROVED BUT THE CHILD COMPLAINS OF NUMBNESS OF THE SAME FOREARM. TESTING IN THE OFFICE SHOWS ABNORMAL COLD/HEAT AND DULL/SHARP DISCRIMINATION ON THE EXTENSER SURFACE OF LEFT FOREARM. FOLLOW UP IN TWO WEEKS.
Patient had very sharp pain in back,light headed like she was going to faint, eyes bloodshot,slight tightness in chest. Called 911 rescue squad came after they got her out of store EMT came back in and said she was doing a little better he said it appeared to be syncopy. The took her to ER as a precaution.
pt recv vax 15JAN97 & w/in 24hr of vax pt noticed a single cold sore in mouth which progressed to several;no other provided;
Covid19 breakthrough.  1st vaccine received on 12/31/2020.  78 y/o PMH HTN, DM, BPH, KIdney stone, Hep C, Ulcerative colitis initially tested positive for Covid19 on  1/6/2022 and was doing ok until 01/17/2022 when started having chest pressure and SOB,  Afebrile, o2 sat 2L nC-94%, CT chest-Viral PNA.  Started on oral steroids.
Initial report received on 19 January 2010 from a healthcare professional, who also provided follow-up information on 08 February 2010. From the information received on 08 February 2010, it was determined a case narrative was required; therefore the following narrative has captured all case information received to date. A 17 month old male patient received a left thigh intramuscular injection of FLUZONE (lot number U3265KA) and a right thigh intramuscular injection of H1N1 (lot number UT023FA) on 18 January 2010. The initial report stated the patient experienced a whole body red raised rash on 18 January 2010. When seen in the office on 19 January 2010, the physician diagnosed the rash as "hypersensitivity reaction". On an unspecified date prior to the office visit, the parents administered TYLENOL. The patient was not ill at the time of the vaccinations. There were no pre-existing medical conditions, no allergies and no concomitant medications. Previous vaccinations received by the patient were "FLUZONE Pediatric, no preservative (.25 mL) and H1N1 (.25 mL)" on 09 December 2009. The initial report indicated the patient had not recovered. In the follow-up information it was noted that the mother stated the rash was improving, but the physician told her to monitor the "erythematic multiformi" and call the office with any concerns or "if it doesn't clear up". The follow-up information indicated the patient had experienced erythema multiforme. Documents held by sender: None.
collapses while training with cardiac arrest; Initial information received on 27-Jan-2022 regarding an unsolicited valid Social Media serious case received via consumer/non-hcp.  This case involves a 17 years old adolescent and unknown gender patient who collapsed while training with cardiac arrest while receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect influenza vaccine (strength, dose, route, formulation and frequency: unknown) produced by unknown manufacturer (lot number and expiry date: not reported) in unknown administration site as prophylactic vaccination (Flu).  The consumer commented that the list went on and on, and on and it was happening everywhere and was not normal. On an unknown date the patient collapsed while training with cardiac arrest (unknown latency) following the administration of Influenza Vaccine. This event was assessed as medically significant.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (cardiac arrest).  At time of reporting, the outcome was Unknown for the event cardiac arrest.; Sender's Comments: Sanofi company comment dated 07-Feb-2022: This case concerns a 17 years old adolescent and unknown gender patient who collapsed while training with cardiac arrest, after vaccination with vaccine Influenza Vaccine. Time to onset of the event is unknown. Information regarding condition at the time of vaccination, medical history and concomitant medication would be needed to rule out the alternative etiology. Based on the reported information, the role of an individual vaccine cannot be assessed.
Pt developed blisters in hands and arms around 4 weeks after immunizations. 2 weeks after blisters he developed bruising. Platelets were down to 6,000. His diagnosis was acute ITP.
Severe HA with mild myalgia.  Felt feverish but temp never exceeded 98.6.
Syncope 10 minutes following vaccination.  While waiting in waiting room following vaccine, patient was observed to begin leaning sideways in chair.  Staff rushed to side. Within a minute patient "came to".  Stated she  "blacked out".   Cold washcloth applied to forehead and patient was then instructed to wait for another half hour before leaving. After 5-10 minutes of waiting patient stated she felt fine and waited approx. 20 minutes longer before leaving facility.  Patient was called approx. 1/2 hr after leaving and stated she felt fine.
Patient presented to the clinic today reporting onset of pain to posterior left knee with swelling to left lower leg and ankle on 4/14/21. Patient sent to local hospital for venous ultrasound of left leg which showed thrombus to left distal superficial femoral vein, popliteal vein, and peroneal vein. Patient was then sent over the emergency department where he was evaluated and started on Eliquis.
My Legs became weak; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (My Legs became weak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ASENAPINE MALEATE (SAPHRIS), ZOLPIDEM TARTRATE (AMBIEN), CARBAMAZEPINE (TEGRETOL), DISULFIRAM (ANTABUSE), VALBENAZINE TOSILATE (INGREZZA), TRAZODONE, CHLORPROMAZINE (THORAZINE [CHLORPROMAZINE]), CLONAZEPAM (KLONOPIN) and ACETYLSALICYLIC ACID (ASPIRIN LOW) for an unknown indication.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (My Legs became weak). At the time of the report, MUSCULAR WEAKNESS (My Legs became weak) outcome was unknown.              Treatment medication was not reported.
Information has been received from a health care care worker concerning a 75 year old female with no pertinent medical history who in 1999 was vaccinated with a dose of PNEUMOVAX 23. On 18-OCT-2007 the patient was vaccinated intramuscularly with a 0.5 ml dose of PNEUMOVAX 23 (Lot #658075/0962U). Concomitant vaccination on the same day included a influenza virus vaccine (unspecified). On 18-OCT-2007 during the day the patient developed fever and chills, in the evening the patient developed pain at the injection site. the patient called the office. Subsequently the symptoms lasted for 24 hours and resolved on 19-OCT-2007. Additional information has been requested.
Severe right arm pain. Emergency room visit. Pain went from arm to hands to legs. Could not work. Dr visit did not find anything the first time. Second visit tested for RA and came back positive. Dr put me on 20MG PredniSone daily. This helped with the severe pain. Never had this before the Covid vacination. I am now seeing a Rheumatologist to try and help with the pain.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 84-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included blood pressure abnormal (receiving blood pressure medication (not specified)). On 5th June 2018 12:30, the patient received the 1st dose of SHINGRIX. In June 2018, 2 days after receiving SHINGRIX, the patient experienced shingles and blister. On an unknown date, the outcome of the shingles was not recovered/not resolved and the outcome of the blister was unknown. It was unknown if the reporter considered the shingles and blister to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the daughter of the patient. The patient received SHINGRIX in the left arm. Two days (couple of days) after receiving SHINGRIX, the patient had 5 shingles blisters.
15sec tonic-clonic sz approx 24 hrs p/DTP; Admitted to hosp given Phenobarbital & a full sepsis work-up; Given IV Ampicillin & Ceftoxine; Pt had respiratory arrest, & was intubated;
3 days p/vax pt c/o h/a, achiness in back & dizziness;pt had fever of 100 & congestion;s&s were present x 3 days;APAP given;MD was not consulted;
Awoke that morning with my right eye crusted shut. Just right eye was red and watery until Wednesday 7/14/2021. By Wednesday afternoon my left eye also became red and watery with thick discharge near the evening. There was no eye pain until Friday 7/16/2020.  As of Saturday 07/17/2021 both eyes are still red and have a general feeling of irritation.
Left arm swelled three times the size of her other arm, extremely dark red and hot to touch.
Interstitial Cystitis flare, inflammatory response in pelvic area, fully body itchiness.
PI:  The pt is a 40 year old female who presents with syncope 20 minutes post Moderna dose #1 vaccination to the left deltoid. Pt syncopized from a seated position, falling forward and catching herself with her arms outstretched. +LOC before immediately regaining consciousness. No head or neck injury, +abrasion to the left elbow. Pt notes similar episode following an influenza vaccine 15 years ago. Pt denies any medical Hx, daily medications, or Hx of anaphylaxis. Pt denies swelling or itching of the lips, eyes, or face. She also denies any swelling of throat, difficulty breathing, or SOB.  Exam (update as needed): GEN: Alert and oriented x 3 upon immediate evaluation,  HEAD: NCAT EYES: PERRL, EOMI ENT: Ears normal, Nose normal, OP normal, no evidence of angioedema NECK: Supple, without LAD.  CV: RRR,+Bradycardic, +hypotensive, no m/r/g PULM:  Clear to auscultation bilaterally, no accessory muscle use ABD: Soft, no tenderness. SKIN: +pale, +diaphoretic, +1cm circular abrasion to left elbow, No rashea MSK: FROM, MS 5/5 NEURO: Alert and oriented x 4, CN 2-12 grossly intact, no ataxia   Clinical Impression/Field Tx: Syncope post moderna does #1 vaccination. Impression supported by clinical scenario, vital signs, and Pt?s endorsement of similar incident in the past, Suspicion for anaphylaxis low due to no signs of angioedema, no SOB, and no complaints of itching. Pt also denied any Hx of anaphylaxis or allergic reaction. Vital signs stabilized in the field and pt reported improvement following 30 minutes of repositioning and observation. Because of limited resources on site, the Pt was evaluated by EMS where repeat vital signs, blood glucose, and EKG were obtained.    Medications administered: None     Disposition:  Pt was evaluated by EMS and transported to the  Hospital.
Yeast infection; This is a spontaneous report from a Pfizer-sponsored program, Accredo Xeljanz Program. The contactable nurse and consumer (patient) reported that a 44-year-old female patient (unknown if pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration, on 29Mar2021 (at the age of 44 years), as dose 2, single, for COVID-19 immunization; and tofacitinib citrate (XELJANZ XR Tablet; Strength: 11 mg, Expiration Date: 30Jan2023), oral, from Apr2016 to 2021, at 11 mg, once daily, for rheumatoid arthritis. The patient's medical history was not reported. The patient's concomitant medication included methotrexate. The patient previously took codeine/ paracetamol (ACETAMINOPHEN;CODEINE Elixir) and experienced allergies. The patient got her second COVID-19 vaccine on 29Mar2021 and was told to hold her tofacitinib citrate for a week when getting the vaccine. While off of tofacitinib citrate for the week, the patient was also treated for a yeast infection (2021). The patient was started back on tofacitinib citrate a week after getting COVID-19 vaccine (Apr2021). The physician was aware. The action taken in response to the event for tofacitinib citrate was post-therapy. The outcome of the event was unknown.  Information about lot or batch number for the suspect product will be requested in follow-up attempts.
Initial misuse report received from a healthcare professional on 16 October 2013. The cases were received on 21 March 2014 at GPV. This case is link with case: 2014SA045133 with same product and same reporter. A 80 years old patient, received FLUZONE HD (No other information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
received 1st dose of Heplisav B on 03/08/2021. Broke out in a systemic rash 03/12/2021. Patient went to PCP for treatment. Given Benadryl, PCP started steroids.
Vaccination adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported. No treatment information was reported.
Patient's arm was swollen, red, and hot. The area was about the size of a palm 4 x 4 inches. No treatment was given to the patient.
A few hours after second dose of Moderna Vaccine,   I began having joint pain.  That was on 5/6/21 it is now 6/4/21,  the joint pain has not subsided and has gotten worse.    Fingers, Hands, Wrist, Shoulders, Knees and Feet and ache and hands get very stiff.
She has a UTI and was hospitalized; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0217), via an unspecified route of administration on 07Jul2021 at dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received her first dose of the Pfizer COVID-19 vaccine on 07Jul2021 and the second dose was scheduled for 28Jul2021. After her first dose, she experienced urinary tract infection (UTI) on an unspecified date in 2021 and was hospitalized from an unspecified date in 2021. She was now in a rehab facility and would like to have someone come out to give her the second dose of the vaccine. For her first dose, she called the state health department and they sent someone to give her the vaccine. She then stated that she has been on the phone for 2 hours and has 5 numbers that she called, and she would just like to schedule her second dose. She stated, "I just want my second dose, but I guess they just want me to die". The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Onset of vesicular painful rash and burning in left thigh on 10/21/22
Approximately 40 minutes after injection, patient returned to area where shots were being administered. He was very short of breath, pale, and diaphoretic. Complained of SOB and throat swelling. 911 was called immediately. Benadryl 50mg IM and EPI 1:1000 .3 SQ was administered immediately. Patient's symptoms improved prior to ambulance arrival. Patient transported to nearest hospital.   12/22/05 Reviewed medical records. Additional symptoms include flushing, nausea, chest pain, and felt faint/lightheaded. Treated with NTG, phenergan, morphine, and Lovenox (antithrombotic).
There were no adverse reactions at this time. She was given 2 tdaps. one on 5/2/23 and another 6/28/2023
This spontaneous prospective pregnancy report was received from a physician refers to a female patient of unknown age. The physician reported that the female pregnant patient was vaccinated with VARIVAX (Merck) (dose, route and frequency were not reported) on 11-FEB-2014. The physician stated that the patient last menstrual period was on 29-JAN-2014. No ultrasound has been performed. No adverse effects were reported. Additional information has been requested.
Chills.  101 fever.   12 hours after injection.   Dizziness at time of injection.       Cold.   Aches.   Sore arm.
Lt arm: 4 mm bruising, 2.5 mm induration with 1 cm erythematous margins. Warm to touch, tender to touch. No SOB, respiratory S/S.
p/vax of 2/99-in late spring 99 pt exp severe persistent low back pain radiating to leg & arm; pain wrist to above elbow & bone deep; unresponsive to meds; devel finger tingling;inc asthma sx;aches; chills;fatigue;pain worse prior to menses
Pfizer monovalent vaccine administered as a booster instead of a Pfizer bivalent vaccine.
When putting in needle, patient said felt like iron going in. When finished injecting, she said felt like shot going up neck, tasted in mouth, feet twitched. This feeling had stopped within a few minutes. She left the immunization booth saying that she felt ok and these side effects had stopped.
Swollen (L) arm, red, hot to the touch spreading to the entire (L) arm, itchy, painful. Pt applies ice, takes BENADRYL, Ibuprofen OTC.
Pt recvd series of vax 1May91; 6Jun91; 28Oct91. Lab tests conducted 20Dec91 indicated that pt was not immune.Also takes Darvocet ro migraines & Anaprox for ovarian cyst.
After receiving his first immunization the patient complained of some generalized itching for several days after the shot. He did not seek any medical treatment at that time. After receiving his second immunization the patient reports the appearance of a rash located over the left and right forearms several days later. This rash appears papular in nature, itching and is in an area measuring about 2 -3 cm in circumference. The patient was treated with triamcinolone cream and diphenhydramine 25 mg.
This spontaneous report was received from a licensed practical nurse refers to a 15 year old patient. On 17-APR-1999, 10-MAY-1999 and 04-NOV-2000, the patient was vaccinated with the first, second and third pediatric dose of RECOMBIVAX HB respectively. The nurse stated that the second dose was only 23 days. No adverse effects reported. Additional information has been requested.
No radiation of pain, but does have weakness to range of motion of the shoulder, and occasional paresthesias to hand. Left shoulder with diffuse tenderness in subacromial region to palpation and range of motion, with decreased flexion and abduction due to pain, nontender elsewhere, no erythema, edema or ecchymosis, left arm nontender, with grossly normal strength and sensation.